These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9754226)
21. Evaluation of Epstein-Barr virus (EBV) antibody screening of organ donors for allocation of organs to EBV serostatus matched recipients. Lazda VA Transplant Proc; 2006 Dec; 38(10):3404-5. PubMed ID: 17175286 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method. Corrales I; Giménez E; Navarro D Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of a multiplex fluorescent microsphere immunoassay for the determination of epstein-barr virus serologic status. Martins TB; Litwin CM; Hill HR Am J Clin Pathol; 2008 Jan; 129(1):34-41. PubMed ID: 18089487 [TBL] [Abstract][Full Text] [Related]
24. Infectious antibodies in systemic lupus erythematosus patients. Berkun Y; Zandman-Goddard G; Barzilai O; Boaz M; Sherer Y; Larida B; Blank M; Anaya JM; Shoenfeld Y Lupus; 2009 Nov; 18(13):1129-35. PubMed ID: 19880558 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842 [TBL] [Abstract][Full Text] [Related]
26. [Determination of IgM and IgG antibodies against the Epstein-Barr virus capsid antigen using the indirect immunofluorescence method (author's transl)]. Presecki V; Borcić D; Vince-Ribarić V; Kulundzić M; Bacun-Kubović M Lijec Vjesn; 1979 Sep; 101(9):535-40. PubMed ID: 232207 [No Abstract] [Full Text] [Related]
27. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer. Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196 [TBL] [Abstract][Full Text] [Related]
28. Sensitivity of the Enzygnost anti-EBV/IgG for the determination of the Epstein-Barr virus immune status in pediatric patients. Kleines M; Scheithauer S; Ritter K; Häusler M Diagn Microbiol Infect Dis; 2006 Jul; 55(3):247-9. PubMed ID: 16545933 [TBL] [Abstract][Full Text] [Related]
29. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723 [TBL] [Abstract][Full Text] [Related]
30. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173 [TBL] [Abstract][Full Text] [Related]
31. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly. Ternák G; Szúcs G; Uj M Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661 [TBL] [Abstract][Full Text] [Related]
32. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease]. Kuljić-Kapulica N Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363 [TBL] [Abstract][Full Text] [Related]
33. [Comparison of 2 fluorescence assays for the diagnosis of Epstein-Barr virus infections]. de Ory F; Guisasola ME Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):442-3. PubMed ID: 9887641 [No Abstract] [Full Text] [Related]
34. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282 [TBL] [Abstract][Full Text] [Related]
36. Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis. Guerrero-Ramos A; Patel M; Kadakia K; Haque T Clin Vaccine Immunol; 2014 Jun; 21(6):817-23. PubMed ID: 24695777 [TBL] [Abstract][Full Text] [Related]
37. [Clinical study on antibodies against EBV in sera of patients with rheumatoid arthritis]. Zhang X; Li B; Liu Y; Jiang M Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):8-12. PubMed ID: 12569633 [TBL] [Abstract][Full Text] [Related]
38. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma. Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156 [TBL] [Abstract][Full Text] [Related]
39. Correlation between the immunological condition and the results of immunoenzymatic tests in diagnosing infectious mononucleosis. Tamaro G; Donato M; Princi T; Parco S Acta Biomed; 2009 Apr; 80(1):47-50. PubMed ID: 19705620 [TBL] [Abstract][Full Text] [Related]
40. Study of the titers of anti-Epstein-Barr virus antibodies in the sera of atomic bomb survivors. Akiyama M; Kusunoki Y; Kyoizumi S; Ozaki K; Mizuno S; Cologne JB Radiat Res; 1993 Mar; 133(3):297-302. PubMed ID: 8383861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]